Microbes and Infectious Diseases (Aug 2022)

Do CRP levels predict severity in COVID-19 hospitalized Egyptian patients?

  • Mayada Moneer,
  • Shaimaa Fouad,
  • Mohamed Allam,
  • Sara Taha,
  • Ahmed Okba,
  • Amr Hosny,
  • Lamiaa El-Moussely,
  • Sylvia Roman

DOI
https://doi.org/10.21608/mid.2022.129490.1264
Journal volume & issue
Vol. 3, no. 3
pp. 534 – 543

Abstract

Read online

Background: Coronavirus disease 2019 (COVID-19) is a rapidly spreading virus with a wide range of clinical manifestations. To manage treatment programs and promptly assess patient severity, prognostic factors must be identified early. Objectives: The purpose of this study was to investigate if there was a link between the severity of COVID-19 and the C-reactive protein (CRP) level on admission. Methods: On admission clinical and laboratory data from 323 patients with laboratory-confirmed COVID-19 were gathered from an Isolation Hospital records from April 10, 2020 to July 30, 2020. CRP was determined in all participants using an automated analyzer and a commercially available latex-enhanced immuno-turbidimetric assay. Results: The most prevalent presenting symptom was fever (39.3%), followed by cough (38.4%). Coronavirus disease 2019 severity and ICU admission were both predicted by high CRP levels (p <0.001). Conclusion: Serum CRP is a simple and effective prognosticator for early prediction of COVID-19 severity.

Keywords